150 related articles for article (PubMed ID: 6593)
1. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum.
Weiden PL; Storb R; Slichter S; Warren RP; Sale GE
J Immunol; 1976 Jul; 117(1):143-50. PubMed ID: 6593
[TBL] [Abstract][Full Text] [Related]
2. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum.
Storb R; Floersheim GL; Weiden PL; Graham TC; Kolb HJ; Lerner KG; Schroeder ML; Thomas ED
J Immunol; 1974 Apr; 112(4):1508-16. PubMed ID: 4592604
[No Abstract] [Full Text] [Related]
3. Use of antithymocyte serum in clinical and experimental marrow transplantation.
Storb R; Weiden PL; Thomas ED
Postgrad Med J; 1976; 52(5 Suppl):96-103. PubMed ID: 11456
[TBL] [Abstract][Full Text] [Related]
4. Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
Schwarzinger I; Raff RF; Flowers M; Niederwieser D; Graham T; Shulman H; Appelbaum FR; Schuening F; Storb R
Bone Marrow Transplant; 1994 Mar; 13(3):303-9. PubMed ID: 8199572
[TBL] [Abstract][Full Text] [Related]
5. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
[TBL] [Abstract][Full Text] [Related]
6. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
7. Effect of time on sensitization to hemophoietic grafts by preceding blood transfusion.
Weiden PL; Storb R; Kolb HJ; Graham TC; Kao G; Thomas ED
Transplantation; 1975 Mar; 19(3):240-4. PubMed ID: 1094638
[TBL] [Abstract][Full Text] [Related]
8. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
[TBL] [Abstract][Full Text] [Related]
9. Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts.
Loughran TP; Raff RF; Graham TC; Appelbaum FR; Schuening FG; Sale GE; Storb R
Exp Hematol; 1990 Nov; 18(10):1126-31. PubMed ID: 2209768
[TBL] [Abstract][Full Text] [Related]
10. Canine marrow transplantation: are serum blocking factors necessary to maintain the stable chimeric state?
Tsoi MS; Storb R; Weiden PL; Graham TC; Schroeder ML; Thomas ED
J Immunol; 1975 Feb; 114(2 Pt 1):531-9. PubMed ID: 1091699
[TBL] [Abstract][Full Text] [Related]
11. Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts.
Bean MA; Graham T; Appelbaum FR; Deeg HJ; Schuening F; Sale GE; Storb R
Transplantation; 1994 Feb; 57(3):423-6. PubMed ID: 8108879
[TBL] [Abstract][Full Text] [Related]
12. Effect of anti-donor serum (ADS) and donor cells on renal allograft survival in DL-A tissue-typed littermate beagles.
Jeekel J; Obertop H; Vriesendorp HM; McDicken I; Westbroek DL
Transplant Proc; 1975 Sep; 7(3):435-8. PubMed ID: 1099744
[TBL] [Abstract][Full Text] [Related]
13. Preceding transfusions and marrow graft rejection in dogs and man.
Weiden PL; Storb R; Thomas ED; Graham TC; Lerner KG; Buckner CD; Fefer A; Neiman PE; Clift RA
Transplant Proc; 1976 Dec; 8(4):551-4. PubMed ID: 793113
[No Abstract] [Full Text] [Related]
14. Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance.
Weiden PL; Storb R; Tsoi MS; Graham TC; Lerner KG; Thomas ED
J Immunol; 1976 May; 116(5):1212-9. PubMed ID: 774975
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of murine allogeneic bone marrow chimeras: effect of anti-lymphocyte serum and bone marrow dose.
Norin AJ; Emeson EE; Veith FJ
J Immunol; 1981 Feb; 126(2):428-32. PubMed ID: 7451985
[TBL] [Abstract][Full Text] [Related]
16. Treatment of canine malignancies by 1200 R total body irradiation and autologous marrow grafts.
Weiden PL; Storb R; Lerner KG; Kao GF; Graham TC; Thomas ED
Exp Hematol; 1975 Apr; 3(2):124-34. PubMed ID: 1095380
[TBL] [Abstract][Full Text] [Related]
17. Tolerance induction in a large-animal model using total lymphoid irradiation and intrathymic bone marrow.
Horton PJ; Hawthorne WJ; Walters S; Patel T; Stewart GJ; Allen RD; Chapman JR
Transplantation; 2008 Dec; 86(12):1830-6. PubMed ID: 19104430
[TBL] [Abstract][Full Text] [Related]
18. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
Kedar E; Or R; Naparstek E; Zeira E; Slavin S
Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477
[TBL] [Abstract][Full Text] [Related]
19. Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients.
Ladiges WC; Storb R; Raff RF; Appelbaum FR; Sandmaier B; Schuening F; Graham T
Bone Marrow Transplant; 1990 Jan; 5(1):43-6. PubMed ID: 2297589
[TBL] [Abstract][Full Text] [Related]
20. Splenectomy does not enhance engraftment of DLA-nonidentical marrow transplants.
Raff RF; Loughran TP; Graham T; Pepe M; Johnston B; Sale GE; Storb R
Exp Hematol; 1993 Feb; 21(2):385-7. PubMed ID: 8425577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]